BridgeBio have substantially improved this course of a novel therapy for amyloid heart disease, utilizing the investigational drug. Initial patient data suggests significant outcomes for patients affected from the https://bridgebio279093.total-blog.com/firm-progresses-amyloidosis-treatment-through-the-drug-67721786